Efficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan

BACKGROUND: Whether the non-inferior efficacy and safety results of switching virologically suppressed HIV-1-infected patients from nevirapine immediate-release (NVP-IR) to NVP extended-release (NVP-XR) demonstrated in the TRANxITION study conducted in Europe and North America are also applicable to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chun-Yuan, Chang, Hui-Min, Kunin, Calvin M, Lee, Susan Shin-Jung, Chen, Yao-Shen, Tsai, Hung-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387218/
https://www.ncbi.nlm.nih.gov/pubmed/28399808
http://dx.doi.org/10.1186/s12879-017-2371-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387218/
https://www.ncbi.nlm.nih.gov/pubmed/28399808
http://dx.doi.org/10.1186/s12879-017-2371-3

Ejemplares similares